Zydus receives tentative approval from USFDA for Ibrutinib tablets 140 mg, 280 mg, and 420 mg Read more
Akums Launches High-Strength Paracetamol Oral Suspension 500mg/5ml for Enhanced Adult and Elderly Care in India Read more
Zydus receives final approval from USFDA for Celecoxib Capsules, 50 mg, 100 mg, 200 mg, and 400 mg Read more
Alembic Pharmaceuticals acquires Utility Therapeutics for $12 million to strengthen U.S. footprint Read more
Alembic Pharmaceuticals Limited announces USFDA Final Approval for Doxorubicin Hydrochloride Liposome Injection Read more
OneSource’s flagship drug-device combination facility in Bangalore maintains its USFDA compliance status Read more
Glenmark Pharmaceuticals to Launch DCGI-approved BRUKINSA in India to Advance Treatment of Hematological Malignancies Read more